Reported Friday, MaNaDr Receives Nasdaq Notice for Minimum Bid Price Rule Violation, Has Until March 2025 to Comply
Portfolio Pulse from Benzinga Newsdesk
MaNaDr, a telehealth provider, received a Nasdaq notice for not meeting the minimum bid price rule, with a deadline until March 2025 to comply. The company must raise its share price above $1.00 for 10 consecutive days to avoid delisting.
September 23, 2024 | 7:08 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MaNaDr received a Nasdaq notice for violating the minimum bid price rule, with a compliance deadline until March 2025. The company must increase its share price above $1.00 for 10 consecutive days to avoid delisting.
The notice from Nasdaq indicates a risk of delisting if MaNaDr does not meet the minimum bid price requirement. This could lead to negative sentiment and pressure on the stock price in the short term. However, the company has time to address the issue, potentially through a reverse stock split.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100